Health Catalyst, Inc. (HCAT) |
| 1.7 -0.03 (-1.73%) 09-11 16:00 |
| Open: | 1.76 |
| High: | 1.77 |
| Low: | 1.69 |
| Volume: | 264,257 |
| Market Cap: | 126(M) |
| PE Ratio: | 8.5 |
| Exchange: | NASDAQ Global Select |
| Industry: | Medical - Healthcare Information Services |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 1.88 |
| Resistance 1: | 1.75 |
| Pivot price: | 1.65 |
| Support 1: | 1.53 |
| Support 2: | 1.27 |
| 52w High: | 3.615 |
| 52w Low: | 0.955 |
Health Catalyst, Inc. equips healthcare providers with crucial data and analytical technologies, alongside specialized services. Their extensive product line features a robust, enterprise-level data and analytics platform designed specifically for the healthcare sector. They additionally offer advanced artificial intelligence (AI) and data science solutions that integrate AI seamlessly into existing business intelligence tools, thereby enhancing analytical precision. The company's services also cover population health management, which identifies areas for improvement throughout the patient care journey, offering actionable recommendations and automated processes. For financial effectiveness, they provide critical insights into cost analysis, workforce efficiency, and revenue maximization. Moreover, Health Catalyst contributes to improving quality and safety by leveraging clinical and patient safety data, sophisticated analytics, and expert consulting. They also facilitate a national data ecosystem, promoting collaborative thought leadership and shared knowledge to generate groundbreaking insights that redefine healthcare delivery. Established in 2008 and based in South Jordan, Utah, the company was formerly known as HQC Holdings, Inc. before officially becoming Health Catalyst, Inc. in March 2017.
| EPS | -3.680 |
| Book Value | 1.350 |
| PEG Ratio | 0.00 |
| Gross Profit | 1.987 |
| Profit Margin (%) | -90.61 |
| Operating Margin (%) | -5.35 |
| Return on Assets (ttm) | -3.0 |
| Return on Equity (ttm) | -118.1 |
Fri, 11 Sep 2026
Mandatory tax sale by Health Catalyst (HCAT) CEO - Stock Titan
Thu, 10 Sep 2026
Planned $59K stock sale at Health Catalyst (NASDAQ: HCAT) - Stock Titan
Tue, 08 Sep 2026
Investor group asks for clearer plan at Health Catalyst (NASDAQ: HCAT) - Stock Titan
Tue, 08 Sep 2026
Health Catalyst gets a new chief after he led a healthcare company through a roughly $670 million sale. - Stock Titan
Thu, 03 Sep 2026
Equity grant lifts Health Catalyst (HCAT) director to 185K shares - Stock Titan
Mon, 10 Aug 2026
Why Health Catalyst (HCAT) Shares Are Trading Lower Today - Yahoo Finance
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |